Posts by: Charles Moore

Charles Moore

Charles Moore is a syndicated columnist for several major Canadian print newspapers and the Science and Research Section editor for CF News Today.

March 15, 2016March 15, 2016

New CF Airway Clearance Monitoring System, inCourage, Promotes At-Home Treatment

News

St. Paul, Minnesota-based RespirTech, specialists in the design and manufacture of Airway Clearance Therapy (ACT) vest devices for persons with lung disorders, recently announced the discovery of a novel way ... Read more

March 11, 2016March 11, 2016

Real Stories: Recognizing and Reducing the Burden of Cystic Fibrosis Treatments

News

Huge strides have been made in the treatment and management of cystic fibrosis (CF) in the past several decades. According to the U.S. National Institutes of Health (NIH), in 1962 the ... Read more

February 29, 2016April 21, 2016

AffloVest Airway-Clearance Device, for Patients with Cystic Fibrosis and Other Respiratory Diseases, Now Made in America

News

Austin, Texas-based International Biophysics Corporation, maker of AffloVest — a completely self-contained, battery operated, portable high-frequency chest wall oscillation (HFCWO) device for bringing critical therapy to people struggling with cystic ... Read more

February 1, 2016February 1, 2016

CysticLife CF Community Partners with Mayo Clinic to Conduct World’s Largest CF Exercise Study

News

CysticLife.org, the largest patient-led social network for the cystic fibrosis (CF) community with more than 8,600 members, has partnered with researchers at the Mayo Clinic to conduct what it says will ... Read more

January 21, 2016July 4, 2016

‘Salty Kids’ to Capture Challenges of Children and Families Living with Cystic Fibrosis

News, SaltyGirlAndDaughter Blog

Ian Ross Pettigrew, the Hamilton, Ontario-based photographer and the creator of the Salty Girls photo project and book of the same name, is carrying on with the next stage of his ... Read more

December 2, 2015December 2, 2015

Cystic Fibrosis Phase 2 Trial of Drug Aiming to Stabilize Key CF Gene Underway

cystic fibrosis, News

Nivalis Therapeutics, Inc., a Boulder, Colorado-based clinical stage pharmaceutical company, announced that the first patient has been dosed in the Phase 2 clinical trial of its lead investigational drug, N91115, a stabilizer ... Read more

November 18, 2015November 19, 2015

Vertex Receives Two European Union Approvals for Cystic Fibrosis Drug KALYDECO (ivacaftor)

News

Cambridge, Massachusetts based Vertex Pharmaceuticals Incorporated reports that the European Commission (EC) has approved expansion of the indication for its cystic fibrosis drug KALYDECO (ivacaftor), which now includes children aged ... Read more

November 17, 2015November 17, 2015

Study Finds Gene Therapy Promising Candidate For Cystic Fibrosis Treatment

News

Encouraging results of a study presented by the Katholieke Universiteit (KU) Leuven Laboratory for Molecular Virology and Gene Therapy at Leuven, Belgium indicate that improved gene therapy treatment can cure ... Read more

October 27, 2015October 27, 2015

Vertex, CRISPR to Use Gene Editing in Search for New Cystic Fibrosis Treatments

News

Vertex Pharmaceuticals, Inc. and CRISPR Therapeutics have announced that they will collaborate on drug research and development using CRISPR’s proprietary gene editing technology CRISPR-Cas9 to discover novel, potential treatments that address the underlying genetic ... Read more

October 26, 2015October 27, 2015

Cystic Fibrosis Trust Puts Young People in Driver’s Seat of Crowdsourcing Effort

News

Persons with Cystic Fibrosis (CF) between ages 11 and 25 who think they can help inspire and engage other young people living with CF are being invited to check out ... Read more